HomeCompareJSPCF vs MRK

JSPCF vs MRK: Dividend Comparison 2026

JSPCF yields 3.64% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JSPCF wins by $1.11M in total portfolio value
10 years
JSPCF
JSPCF
● Live price
3.64%
Share price
$14.76
Annual div
$0.54
5Y div CAGR
60%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.17M
Annual income
$784,719.57
Full JSPCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JSPCF vs MRK

📍 JSPCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJSPCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JSPCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JSPCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JSPCF
Annual income on $10K today (after 15% tax)
$309.33/yr
After 10yr DRIP, annual income (after tax)
$667,011.63/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, JSPCF beats the other by $658,683.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JSPCF + MRK for your $10,000?

JSPCF: 50%MRK: 50%
100% MRK50/50100% JSPCF
Portfolio after 10yr
$613.6K
Annual income
$397,258.86/yr
Blended yield
64.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JSPCF
No analyst data
Altman Z
82.5
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JSPCF buys
0
MRK buys
0
No recent congressional trades found for JSPCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJSPCFMRK
Forward yield3.64%2.76%
Annual dividend / share$0.54$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR60%32.7%
Portfolio after 10y$1.17M$56.8K
Annual income after 10y$784,719.57$9,798.13
Total dividends collected$1.11M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JSPCF vs MRK ($10,000, DRIP)

YearJSPCF PortfolioJSPCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,282$582.27$11,206$366.19+$76.00JSPCF
2$13,054$982.32$12,650$502.35+$404.00JSPCF
3$15,668$1,699.61$14,407$694.19+$1.3KJSPCF
4$19,815$3,050.26$16,585$967.82+$3.2KJSPCF
5$26,970$5,768.39$19,342$1,363.89+$7.6KJSPCF
6$40,599$11,740.48$22,913$1,947.19+$17.7KJSPCF
7$69,868$26,427.08$27,662$2,823.89+$42.2KJSPCF
8$142,765$68,006.46$34,159$4,173.35+$108.6KJSPCF
9$360,552$207,793.40$43,337$6,308.80+$317.2KJSPCF
10$1,170,510$784,719.57$56,776$9,798.13+$1.11MJSPCF

JSPCF vs MRK: Complete Analysis 2026

JSPCFStock

JSP Corporation manufactures and sells expanded polymers worldwide. The company offers materials products, such as ARPRO, an impact energy management material that is used in automotive applications, multi-use transport packaging, HVAC housings, and others; STYRODIA for use in various applications comprising packaging for consumer electronics, hot and cold food containers, construction insulation, and within civil engineering materials; and FOAMCORE that is used in prefabricated bathrooms and automotive components. It also provides sheet and board products under the MIRAMAT, CAPLON, P-BOARD, STYRENE PAPER, MIRABOARD, and MIRAFOAM names for advertising boards, construction, food packaging, and industrial packaging markets. The company was incorporated in 1962 and is headquartered in Tokyo, Japan. JSP Corporation is a subsidiary of Mitsubishi Gas Chemical Company, Inc.

Full JSPCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JSPCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JSPCF vs SCHDJSPCF vs JEPIJSPCF vs OJSPCF vs KOJSPCF vs MAINJSPCF vs JNJJSPCF vs ABBVJSPCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.